CRAI trades 19.7% below Wall Street's consensus target of $194.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRAI achieves its forward estimates and maintains a stable P/E multiple of 19.7x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, CRA International, Inc. (CRAI) has a Wall Street consensus price target of $194.00, based on estimates from 1 covering analysts. With the stock currently trading at $162.02, this represents a potential upside of +19.7%. The company has a market capitalization of $1.05B.
Analyst price targets range from a low of $194.00 to a high of $194.00, representing a 0% spread in expectations. The median target of $194.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRAI trades at a trailing P/E of 19.9x and forward P/E of 19.7x. The forward PEG ratio of 0.91 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +7.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $178.43, with bear and bull scenarios of $112.41 and $235.10 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HURNHuron Consulting Group Inc. | $2.5B | $159.91 | $176.00 | +10.1% | Buy | 17.4x | 9 |
 FTITechnipFMC plc | $28.4B | $71.24 | $78.25 | +9.8% | Buy | 22.9x | 50 |
 EXPOExponent, Inc. | $3.2B | $65.41 | $72.00 | +10.1% | Buy | 31.8x | 8 |
 FORRForrester Research, Inc. | $229M | $11.78 | — | — | Hold | 15.2x | 4 |
 ICFIICF International, Inc. | $1.5B | $83.68 | $110.00 | +31.5% | Buy | 11.8x | 13 |
 MCOMoody's Corporation | $82.1B | $473.93 | $540.60 | +14.1% | Buy | 28.0x | 32 |
 VRSKVerisk Analytics, Inc. | $22.4B | $171.80 | $225.43 | +31.2% | Hold | 22.3x | 25 |
 CSGPCoStar Group, Inc. | $11.5B | $28.26 | $36.36 | +28.7% | Buy | 20.7x | 27 |
 ACNAccenture plc | $112.3B | $183.52 | $200.65 | +9.3% | Buy | 13.2x | 53 |
 BAHBooz Allen Hamilton Holding Corporation | $9.1B | $75.65 | $89.00 | +17.6% | Buy | 12.5x | 22 |
Quick answers to the most common questions about buying CRAI stock.
CRA International, Inc. (CRAI) has a consensus 12-month price target of $194, implying 19.7% upside from $162.02. The 1 analysts covering CRAI see moderate appreciation potential.
CRAI has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $194 implies 19.7% upside from current levels.
With a forward P/E of 19.6598x, CRAI trades at a relatively low valuation. The consensus target of $194 implies 19.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $194 for CRAI, while the most conservative target is $194. The consensus of $194 represents the median expectation. Our quantitative valuation model projects a bull case target of $235 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRAI is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRAI stock forecast based on 1 Wall Street analysts shows a consensus price target of $194, with estimates ranging from $194 (bear case) to $194 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $178, with bear/bull scenarios of $112/$235.
Our quantitative valuation model calculates CRAI's fair value at $178 (base case), with a bear case of $112 and bull case of $235. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
CRAI trades at a forward P/E ratio of 19.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 19.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CRAI, with a "Buy" consensus rating and $194 price target (19.7% upside). 1 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRAI analyst price targets range from $194 to $194, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $194 consensus represents the middle ground. Our model's $112-$235 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.